Pembrolizumab for the first-line treatment of non-small cell lung cancer

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pembrolizumab for the first-line treatment of non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds